This brand name is authorized in Germany
The drug TRI-NORMIN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Atenolol
UNII 50VV3VW0TI - ATENOLOL
|
|
Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. |
|
2
Chlortalidone
UNII Q0MQD1073Q - CHLORTHALIDONE
|
|
Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action. |
|
3
Hydralazine
UNII FD171B778Y - HYDRALAZINE HYDROCHLORIDE
|
|
Hydralazine is a direct acting vasodilator which exerts its effects principally on the arterioles. Its precise mode of action is not known. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07CB53 | Atenolol and other diuretics, combinations | C Cardiovascular system → C07 Beta blocking agents → C07C Beta blocking agents and other diuretics → C07CB Beta blocking agents, selective, and other diuretics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut fĂźr Arzneimittel und Medizinprodukte | Identifier(s): 02767326, 02767349, 03060907 |
Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
